JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 8 No. 2, March 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Abuse of Dextromethorphan

The American Medical Association's House of Delegates recently raised concerns about the dangers of misuse of dextromethorphan hydrobromide by young people (Resolution 407, adopted at the 1997 Interim Meeting). This letter is intended to provide a brief review of this subject for primary care physicians.

Dextromethorphan is a highly effective nonopioid antitussive drug. This drug, either alone or in combination with other drugs, is widely available in over-the-counter cough and cold drug products in the United States. When the recommended dosage is followed (adults and children aged 12 years and older, 60-120 mg daily in divided doses; children aged 6-12 years, 30-60 mg daily in divided doses; and children aged 2-6 years, 15-30 mg daily in divided doses), dextromethorphan is a very safe drug; adverse reactions are infrequent and usually not severe. Although a few cases of toxicity have been reported, doses in excess of 100 times the usual adult dose have not been fatal.1-2

Since dextromethorphan was introduced in the 1960s, episodic and sporadic abuse has been reported in several areas of the world,2-3 although the extent of the abuse is unknown. Case reports of recreational abuse of dextromethorphan have been reported in the United States, Sweden, Australia, Germany, and Canada.3-9 Dextromethorphan is sometimes mixed with street heroin to increase the pharmacologic effects.10 Abuse seems to occur primarily among adolescents and young adults, who can obtain the drug easily. Case reports of intentional abusers generally show that addiction is long-term, ranging from 3 months to many years. Most patients describe acute euphoria after consumption, with intense craving and dysphoria on withdrawal.3 However, physical symptoms of withdrawal have not been reported for dextromethorphan.2-3 Thus, dextromethorphan causes psychological dependence but not physical dependence.

Wolfe and Caravati3 have identified the primary psychological symptoms of dextromethorphan abuse as follows: euphoria, increased perceptual awareness, altered time perception, feelings of floating, tactile hallucinations, visual hallucinations, auditory hallucinations, visual disturbances, paranoia, and disorientation. The primary symptoms of withdrawal are insomnia, dysphoria, and depression.3 Based on studies in animals, it has been suggested that the symptoms observed in abusers of dextromethorphan are caused by the active metabolite dextrorphan, which binds to the same central nervous system receptor as phencyclidine.3

Sixteen case reports of acute dextromethorphan intoxication have been reported in the literature, but most of these ingestions were unintentional.3 In Sweden, two deaths were reported to occur as a result of dextromethorphan ingestion.6 In cases of acute overdose, the primary symptoms are related to the central nervous system and include altered mental status (ranging from somnolence to hyperexcitability), ataxia, and nystagmus.3 Supportive care seems to be all that is necessary.3 While some reports suggest that naloxone is effective in treating acute dextromethorphan intoxication,2 other data raise questions about its usefulness.3

Overdoses of dextromethorphan hydrobromide can also cause bromide poisoning.11 This should be considered in the evaluation of long-term abusers who present with symptoms and laboratory findings that suggest bromide poisoning.3

In summary, dextromethorphan is a widely available over-the-counter antitussive drug that is highly effective and has a wide margin of safety. However, episodic and sporadic abuse of dextromethorphan, especially among adolescents and young adults, has been reported in the last 3 decades. A search on the World Wide Web revealed an extensive and growing number of sites created by laypeople who use the drug and are unaware of medical advice or research related to its use. These sites promote the drug as a "powerful" over-the-counter mind-altering substance. Some relate the personal experiences of users, while several of the sites include detailed information on the psychoactive effects users may expect, dosage levels, some warning indicators, and detailed information on how to extract the drug from over-the-counter preparations. Thus, physicians need to be aware of dextromethorphan's abuse potential, especially among younger patients.

Joseph W. Cranston, PhD; Richard Yoast, PhD
Chicago, Ill

1. McEvoy GK. AHFS 98 Drug Information. Bethesda, Md: American Society of Health-System Pharmacists; 1998:2233-2237.
2. Bem JL, Peck R. Dextromethorphan: an overview of safety issues. Drug Saf. 1992;7:190-199. ISI | PUBMED
3. Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med. 1995;13:174-176. FULL TEXT | ISI | PUBMED
4. McElwee NE, Veltri JC. Intentional abuse of dextromethorphan (DM) products: 1985 to 1988 statewide data [abstract]. Vet Hum Toxicol. 1990;32:355.
5. Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993;86:1151-1153. FULL TEXT | ISI | PUBMED
6. Rammer L, Holmgren P, Sandler H. Fatal intoxication by dextromethorphan: a report on two cases. Forensic Sci Int. 1988;37:233-236. FULL TEXT | ISI | PUBMED
7. McCarthy JP. Some less familiar drugs of abuse. Med J Aust. 1971;21:1078-1081.
8. Degkwitz R. Dextromethorphan (Romilar) als Rauschmittel. Nervenarzt. 1964;35:412-414. PUBMED
9. Craig DF. Psychosis with Vicks Formula 44-D abuse. CMAJ. 1992;146:1199-2000. PUBMED
10. Scopolamine poisoning among heroin users: New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996. MMWR Morb Mortal Wkly Rep. 1996;45:457-460. PUBMED
11. Ng YY, Lin WL, Chen TW, et al. Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol. 1992;12:268-270. ISI | PUBMED

Arch Fam Med. 1999;8:99-100.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Paul et al.
Arch Pediatr Adolesc Med 2007;161:1140-1146.
ABSTRACT | FULL TEXT  

The Prevalence of Dextromethorphan Abuse Among High School Students
Falck et al.
Pediatrics 2006;118:2267-2269.
FULL TEXT  

Adolescent Abuse of Dextromethorphan
Schwartz
CLIN PEDIATR 2005;44:565-568.
ABSTRACT  

Effect of Dextromethorphan, Diphenhydramine, and Placebo on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Paul et al.
Pediatrics 2004;114:e85-e90.
ABSTRACT | FULL TEXT  

Dextromethorphan Abuse Among Youth
Noonan et al.
Arch Fam Med 2000;9:791-792.
FULL TEXT  

Dextromethorphan: Another "Ecstasy"?
McFee et al.
Arch Fam Med 2000;9:123-123.
FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.